Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BP plc
ChromaDex Rides Nestle Deal To 14% Q4 Growth; Mannatech, USANA End Year In Slumps
ChromaDex reports Niagen ingredient sales growth propelled by upfront minimum purchase from Nestlé Health Science; and Mannatech and USANA both reported larger full-year sales dips after ending 2022 in slumps.
USANA Looks Inside US, Outside Nutrition Sector For Growth Drivers, Acquiring Oolah, Rise Bar
USANA also signals its turning outside nutritional products sector for potential growth driver. One of two firms it’s acquiring, Oola Life Inc., also provides life coach services directly to customers as well as nutritional supplements.
US Q3 Health And Wellness Results: Chromadex, Lannett, Mannatech And USANA
ChromaDex trims loss, adds Nestle as Niagen customer; currency exchange slams Mannatech; Asia-Pacific sales, currency exchange Rock USANA results; and Lannett sees upsides after 25% sales slide.
USANA’s Preliminary Earnings Alert Could Signal Trend In Q2 Results Across Consumer Health
Pandemic-related market lockdowns, shipping backlogs and other disruptions in mainland China and other countries USANA referenced in announcement also could affect results for its direct-selling competitors as well as other firms in health, wellness, personal care and beauty industries.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.